Medical Device News Magazine

Philips Recognized with ‘A’ Score for its Climate Action Leadership

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company has been recognized for its climate action leadership by global environmental non-profit CDP. Thanks to its actions to cut emissions, mitigate climate risks, and develop the low-carbon economy, Philips has secured a place on CDP’s ‘A List’ for the ninth consecutive year.

“With health systems and consumers increasingly committed to making more sustainable choices and to climate action, we remain convinced that doing business sustainably is the only way forward,” said Frans van Houten, CEO of Royal Philips. “Our ongoing actions to embed sustainability in our solutions, our operations, and across the supply chain, have once again been recognized with a place on CDP’s prestigious benchmark. I am proud that the creativity and inspiration of our global workforce continue to make a difference in creating a healthier and more sustainable world.”

CDP’s annual environmental disclosure and scoring process is widely recognized as the gold standard of corporate environmental transparency. Its scoring methodology assesses companies on the comprehensiveness of their disclosure, awareness and management of environmental risks and demonstration of best practices associated with environmental leadership, such as setting ambitious and meaningful targets.

Global recognition

To achieve its vision of making the world healthier and more sustainable through innovation, Philips employs a comprehensive set of commitments across all the Environmental, Social, and Governance (ESG) dimensions that guide the execution of company strategy. Philips is already carbon neutral in its operations and is set to further reduce its CO2 emissions in line with 1.5°C global warmings, for example by further improving the energy efficiency of its products during the customer use phase and teaming up with customers and stakeholders to decarbonize healthcare. The company has also set ambitious circular economy objectives, such as generating 25% of its revenue from circular products, services and solutions by 2025. Philips is also taking action to drive the significant reduction of greenhouse gas emissions in its supply chain.

The company’s longstanding commitment to doing business responsibly and sustainably has received widespread recognition. For example, Philips has achieved top positions in the global Dow Jones Sustainability Indices and Sustainalytics rankings, and the company was awarded a top ESG score of 90 out of 100 by S&P Global Ratings. Moreover, Philips was the first health technology company to have its carbon emission targets for the 2020 – 2040 period assessed and approved by the Science-Based Targets initiative (STBi). 

More information about how Philips is partnering with stakeholders to drive environmental, social, and governance priorities and make a global impact, is available here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”